COVID-19 Vaccine ‘Booster’ Or Simply A Third Dose? US FDA’s Marks Starts To Reframe The Issue

 
• By Kate Rawson
  
High stakes poker
The stakes are high for the FDA advisory committee meeting on a third dose of Pfizer/BioNTech's COVID-19 vaccine. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet